Keep your distance or lose control
In this issue of Blood, Felder et al1 demonstrate that, for normal developmental control of globin gene expression, the enhancer (locus control region [LCR
Related Articles
Counterpoint: the design and interpretation of blood transfusion randomized clinical trials
Designing randomized clinical trials (RCTs) that are fit for purpose to answer burning questions in routine practice is difficult, and the interpretation o
Stereotactic Body Radiotherapy for the Treatment of Adrenal Metastases – A Case-Based Radiosurgery Society Practice Guide and Review
Adrenal metastases are frequently diagnosed in patients with common solid tumors. Surgical adrenalectomy has historically been used for their management. However, stereotactic body radiotherapy (SBRT)…
Melanoma
Get the facts about melanoma, a dangerous form of skin cancer. Learn more about melanoma types, risk factors, warning signs and treatment.
CD News | American Association for Cancer Research
A new targeted therapy aimed specifically at FGFR3, TYRA-300, is showing preliminary promise in patients with advanced FGFR3 -altered bladder cancer. Partial responses have been…
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma
Key PointsS-MRD negativity <10–5 is the best predictor of outcomes in newly diagnosed multiple myeloma.Similar results are seen among patients who achie
Cervical cancer prevention in the United States—where we’ve been and where we’re going: The American Cancer Society Primary HPV Screening Initiative
Click on the article title to read more.
Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24
Key PointsJAK2V617F neutrophils evade homeostatic clearance and accumulate in MPN owing to JAK2-STAT5–dependent upregulation of CD24.CD24 antibody blockade
OCE Oncology News
A monthly newsletter for oncology/hematology fellows, junior faculty and scientists
Inhibition of terminal complement complex formation alleviates murine antibody-mediated TRALI
Key PointsComplement MAC triggers the development of anti-CD36–mediated murine TRALI.Blockage of MAC formation by monoclonal anti-C7 prevented and ameliora
Healio Disruptive Innovators Awards 2024
Take this survey powered by surveymonkey.com. Create your own surveys for free.
